Targeting HER2: Updates on New and Emerging Treatment Approaches in Biliary Tract Cancers and Gastroesophageal Adenocarcinoma for the Community Oncologist
Webinar/Online
Tuesday, November 5, 2024 at 7:00pm CT - 8:00pm CT
This event has ended.
Info
Topic
Gastric Cancers
Credits Offered
This event offers
1.0 CME credit
to attendees.
Accreditation Info:
Accreditation Council for Continuing Medical Education.
Additional Information
Join us for this great CME talk.
Learning Objectives:
- Summarize current data informing HER2 expression assessment in GEA and BTC for HER2
- Analyze the basis for guideline recommendations including diagnostic criteria in the management of HER2-positive GEA and BTC
- Evaluate clinical trial findings involving treatments targeting HER2 in GEA and BTC in the second-line treatment setting and differentiate those treatment options
Speakers
Associate Professor
Dr. Thomas Cartwright is an Associate Professor of Medicine at the University of Central Florida School of Medicine in Ocala, FL.
Event Agenda
Targeting HER2: Updates on New and Emerging Treatment Approaches in Biliary Tract Cancers and Gastroesophageal Adenocarcinoma for the Community Oncologist
Event Agenda
Tuesday, November 5, 2024 at 7:00pm CT - 8:00pm CT
All times listed in
Central Time (US & Canada).
Download event agenda (PDF)
Tuesday, November 5, 2024
-
7:00pm - 8:00pm
Targeting HER2: Updates on New and Emerging Treatment Approaches in Biliary Tract Cancers and Gastroesophageal Adenocarcinoma for the Community Oncologist
Thomas H. Cartwright, MD
1.0 CE CreditLearning Objectives:
- Summarize current data informing HER2 expression assessment in GEA and BTC for HER2
- Analyze the basis for guideline recommendations including diagnostic criteria in the management of HER2-positive GEA and BTC
- Evaluate clinical trial findings involving treatments targeting HER2 in GEA and BTC in the second-line treatment setting and differentiate those treatment options